APO RESEARCH · REPORT
Precision Medicine
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Product & engineering
Understand the product.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
Selected research
Industry Growth & Trends
Global Precision Medicine Industry Growth and Trends Forecast to 2032
Market perspective
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
According to APO Research, the global Precision Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Precision Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Precision Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Precision Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Precision Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Precision Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Precision Medicine Market by Company
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
Precision Medicine Segment by Type
Diagnostics
Therapies
Precision Medicine Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
Precision Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Precision Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostics
- Therapies
Applications
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
Companies covered
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux Sa
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Precision Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Precision Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Precision Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Precision Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Precision Medicine Market Size (2021-2032)
- 1.5.1 North America Precision Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Precision Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Precision Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Precision Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Precision Medicine Market Size Growth Rate (2021-2032)
2 Precision Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Diagnostics
- 2.1.2 Therapies
- 2.2 Global Precision Medicine Market Size by Type
- 2.2.1 Global Precision Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Precision Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Precision Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Precision Medicine Market Size by Regions
- 2.3.1 North America Precision Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Precision Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Precision Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Precision Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Precision Medicine Market Size Breakdown by Type (2021-2026)
3 Precision Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Oncology
- 3.1.2 Neurosciences
- 3.1.3 Immunology
- 3.1.4 Respiratory
- 3.1.5 Others
- 3.2 Global Precision Medicine Market Size by Application
- 3.2.1 Global Precision Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Precision Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Precision Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Precision Medicine Market Size by Regions
- 3.3.1 North America Precision Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Precision Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Precision Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Precision Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Precision Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Precision Medicine Industry Trends
- 4.2 Precision Medicine Industry Drivers
- 4.3 Precision Medicine Industry Opportunities and Challenges
- 4.4 Precision Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Precision Medicine Revenue (2021-2026)
- 5.2 Global Precision Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Precision Medicine Key Company Headquarters & Area Served
- 5.4 Global Precision Medicine Company, Product Type & Application
- 5.5 Global Precision Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Precision Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Precision Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Precision Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Johnson & Johnson Precision Medicine Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Precision Medicine Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Labcorp
- 6.3.1 Labcorp Company Information
- 6.3.2 Labcorp Business Overview
- 6.3.3 Labcorp Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Labcorp Precision Medicine Product Portfolio
- 6.3.5 Labcorp Recent Developments
- 6.4 Abbott Laboratories
- 6.4.1 Abbott Laboratories Company Information
- 6.4.2 Abbott Laboratories Business Overview
- 6.4.3 Abbott Laboratories Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Abbott Laboratories Precision Medicine Product Portfolio
- 6.4.5 Abbott Laboratories Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Novartis Precision Medicine Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Illumina
- 6.6.1 Illumina Company Information
- 6.6.2 Illumina Business Overview
- 6.6.3 Illumina Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Illumina Precision Medicine Product Portfolio
- 6.6.5 Illumina Recent Developments
- 6.7 GE Healthcare
- 6.7.1 GE Healthcare Company Information
- 6.7.2 GE Healthcare Business Overview
- 6.7.3 GE Healthcare Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GE Healthcare Precision Medicine Product Portfolio
- 6.7.5 GE Healthcare Recent Developments
- 6.8 Intel Corporation
- 6.8.1 Intel Corporation Company Information
- 6.8.2 Intel Corporation Business Overview
- 6.8.3 Intel Corporation Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Intel Corporation Precision Medicine Product Portfolio
- 6.8.5 Intel Corporation Recent Developments
- 6.9 Biomrieux Sa
- 6.9.1 Biomrieux Sa Company Information
- 6.9.2 Biomrieux Sa Business Overview
- 6.9.3 Biomrieux Sa Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Biomrieux Sa Precision Medicine Product Portfolio
- 6.9.5 Biomrieux Sa Recent Developments
- 6.10 Cepheid
- 6.10.1 Cepheid Company Information
- 6.10.2 Cepheid Business Overview
- 6.10.3 Cepheid Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Cepheid Precision Medicine Product Portfolio
- 6.10.5 Cepheid Recent Developments
- 6.11 IBM
- 6.11.1 IBM Company Information
- 6.11.2 IBM Business Overview
- 6.11.3 IBM Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 IBM Precision Medicine Product Portfolio
- 6.11.5 IBM Recent Developments
- 6.12 Qiagen
- 6.12.1 Qiagen Company Information
- 6.12.2 Qiagen Business Overview
- 6.12.3 Qiagen Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Qiagen Precision Medicine Product Portfolio
- 6.12.5 Qiagen Recent Developments
- 6.13 Thermo Fisher Scientific
- 6.13.1 Thermo Fisher Scientific Company Information
- 6.13.2 Thermo Fisher Scientific Business Overview
- 6.13.3 Thermo Fisher Scientific Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
- 6.13.5 Thermo Fisher Scientific Recent Developments
- 6.14 Randox Laboratories
- 6.14.1 Randox Laboratories Company Information
- 6.14.2 Randox Laboratories Business Overview
- 6.14.3 Randox Laboratories Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Randox Laboratories Precision Medicine Product Portfolio
- 6.14.5 Randox Laboratories Recent Developments
- 6.15 Almac Group
- 6.15.1 Almac Group Company Information
- 6.15.2 Almac Group Business Overview
- 6.15.3 Almac Group Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Almac Group Precision Medicine Product Portfolio
- 6.15.5 Almac Group Recent Developments
- 6.16 Healthcore
- 6.16.1 Healthcore Company Information
- 6.16.2 Healthcore Business Overview
- 6.16.3 Healthcore Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Healthcore Precision Medicine Product Portfolio
- 6.16.5 Healthcore Recent Developments
7 North America
- 7.1 North America Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Precision Medicine Market Size by Country (2021-2026)
- 7.3 North America Precision Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Precision Medicine Market Size by Country (2021-2026)
- 8.3 Europe Precision Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Precision Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Precision Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Precision Medicine Market Size by Country (2021-2026)
- 10.3 South America Precision Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Precision Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Precision Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst